Flubromazolam

Flubromazolam is a novel synthetic depressant of the triazolobenzodiazepine class that produces anxiolytic, sedative, muscle relaxant, and amnestic effects. It is exceptionally potent, with activity in the microgram range, and possesses an unusually long duration of action. These properties pose heightened risks compared to other designer benzodiazepines, as strong sedation and amnesia can occur even at very low threshold doses. It has not been formally studied and is available exclusively through research chemical vendors.

Also known as: F-lam, Jyi-73, Liquid xanax

Classification

Chemical: Benzodiazepine
Psychoactive: Depressant
Tag: Anxiolytic
Tag: Habit-Forming
Tag: Muscle Relaxant
Tag: Research-Chemical
Tag: Sedative

Effects

Sedation
Respiratory Depression
Muscle Relaxation
Anxiolytic
Sedative
Dystaxia
Amnesia
Anxiety Suppression
Thought Deceleration
Information Processing Suppression
Euphoria
Compulsive Redosing
Disinhibition
Dulled Perception

Routes of Administration

Oral

Dosage

Heavy: 400 ug
Light: 100 – 150 µg
Common: 150 – 250 µg
Strong: 250 – 400 µg
Threshold: 100 ug

Duration

Onset: 0.33-0.75 h
After Effects: 6-24 h

Harm Reduction

Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.

Sources

Substance data is aggregated from the following public harm-reduction and reference sources.

Links

This static page is intended as a readable non-JS and prerender-friendly library export.

Get the full DrugsPRO experience

Open the interactive DrugsPRO app for search, saved items, interactions, and deeper harm reduction tools.

Get the PRO test kit. The simple, quick and reliable drug checking test kit. Visit https://protestkit.eu